The University of Southampton
University of Southampton Institutional Repository

Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK)

Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK)
Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK)
Purpose
The purpose was to describe clinical pharmacist interventions across a range of critical care units (CCUs) throughout the United Kingdom, to identify CCU medication error rate and prescription optimization, and to identify the type and impact of each intervention in the prevention of harm and improvement of patient therapy.

Materials and methods
A prospective observational study was undertaken in 21 UK CCUs from November 5 to 18, 2012. A data collection web portal was designed where the specialist critical care pharmacist reported all interventions at their site. Each intervention was classified as medication error, optimization, or consult. In addition, a clinical impact scale was used to code the interventions. Interventions were scored as low impact, moderate impact, high impact, and life saving. The final coding was moderated by blinded independent multidisciplinary trialists.

Results
A total of 20 517 prescriptions were reviewed with 3294 interventions recorded during the weekdays. This resulted in an overall intervention rate of 16.1%: 6.8% were classified as medication errors, 8.3% optimizations, and 1.0% consults. The interventions were classified as low impact (34.0%), moderate impact (46.7%), and high impact (19.3%); and 1 case was life saving. Almost three quarters of interventions were to optimize the effectiveness of and improve safety of pharmacotherapy.

Conclusions
This observational study demonstrated that both medication error resolution and pharmacist-led optimization rates were substantial. Almost 1 in 6 prescriptions required an intervention from the clinical pharmacist. The error rate was slightly lower than an earlier UK prescribing error study (EQUIP). Two thirds of the interventions were of moderate to high impact.
0883-9441
808-813
Shulman, R.
9c212309-b5b0-41e3-93fe-314a9611a682
McKenzie, C.A.
ec344dee-5777-49c5-970e-6326e82c9f8c
Landa, J.
76de230d-be46-4921-bb19-36fa7c567f9c
Bourne, R.S.
271c1df1-9430-4da0-b71e-f6ee41f5bc59
Jones, A.
bc5119c4-374c-4ecc-a9af-a03bdea88498
Borthwick, M.
cf7d2af4-9ac8-470a-ac61-d5e6e673194b
Tomlin, M.
144c110a-bb06-466a-afbc-07ee36b40b8e
Jani, Y.H.
e0abe5f0-b1ae-4a88-bb65-eaae5a794730
West, D.
fa95ae31-5789-4368-af47-55f4ca8c281a
Bates, I.
b73b683c-b0e6-494e-a529-d930210dd0ac
Shulman, Rob
3c7da7ba-a4fd-4085-8445-b7bbd394eca3
Mc, C.
f0a169e0-cbc6-491f-8ef5-bbc7981939c0
Landa, J.
76de230d-be46-4921-bb19-36fa7c567f9c
Bourne, R.
1fa05452-3d22-4314-86da-ebb63fb32fb9
Tomlin, M.
c32a43be-be15-4ad7-aa43-4d95981c37a0
Ian, B.
ff6f50ff-0f0f-4b3c-97c5-ce97102c6667
West, D.
fa95ae31-5789-4368-af47-55f4ca8c281a
Jani, Y.
4eff155b-f2a2-4dc8-8289-70c67ef5918a
Sapsford, D.
8804b694-0ada-48e3-aeb6-bfa811a938fa
McHale, H.
2f4bad63-b73a-4648-827b-308bc3fc5f61
Hylands, J.
eb05a49b-b6f2-4bbe-b695-1174d7e4b392
Graham-Clarke, E.
6f7f2afe-5beb-4ead-9807-455737950b19
Rudall, N.
16e8bda0-e1ff-4582-a0e8-109219560401
Cadman, B.
49a6a7ae-f3a0-49da-9f22-2840319f4d62
Barton, G.
82f7be35-5f09-4141-93ad-4237116f59c5
Forrest, R.
b7b11839-91f7-4543-907d-d0c1c138111a
Boxall, E.
6dda958a-a662-4354-98a8-a7de5b8c284b
Timmins, A.
fd8a0347-c071-40a9-89ba-5acc3dae3035
Borthwick, M.
cf7d2af4-9ac8-470a-ac61-d5e6e673194b
Thacker, M.
bac5941d-27ba-4d35-ace7-36dcf57073b4
PROTECTED-UK GROUP
Shulman, R.
9c212309-b5b0-41e3-93fe-314a9611a682
McKenzie, C.A.
ec344dee-5777-49c5-970e-6326e82c9f8c
Landa, J.
76de230d-be46-4921-bb19-36fa7c567f9c
Bourne, R.S.
271c1df1-9430-4da0-b71e-f6ee41f5bc59
Jones, A.
bc5119c4-374c-4ecc-a9af-a03bdea88498
Borthwick, M.
cf7d2af4-9ac8-470a-ac61-d5e6e673194b
Tomlin, M.
144c110a-bb06-466a-afbc-07ee36b40b8e
Jani, Y.H.
e0abe5f0-b1ae-4a88-bb65-eaae5a794730
West, D.
fa95ae31-5789-4368-af47-55f4ca8c281a
Bates, I.
b73b683c-b0e6-494e-a529-d930210dd0ac
Shulman, Rob
3c7da7ba-a4fd-4085-8445-b7bbd394eca3
Mc, C.
f0a169e0-cbc6-491f-8ef5-bbc7981939c0
Landa, J.
76de230d-be46-4921-bb19-36fa7c567f9c
Bourne, R.
1fa05452-3d22-4314-86da-ebb63fb32fb9
Tomlin, M.
c32a43be-be15-4ad7-aa43-4d95981c37a0
Ian, B.
ff6f50ff-0f0f-4b3c-97c5-ce97102c6667
West, D.
fa95ae31-5789-4368-af47-55f4ca8c281a
Jani, Y.
4eff155b-f2a2-4dc8-8289-70c67ef5918a
Sapsford, D.
8804b694-0ada-48e3-aeb6-bfa811a938fa
McHale, H.
2f4bad63-b73a-4648-827b-308bc3fc5f61
Hylands, J.
eb05a49b-b6f2-4bbe-b695-1174d7e4b392
Graham-Clarke, E.
6f7f2afe-5beb-4ead-9807-455737950b19
Rudall, N.
16e8bda0-e1ff-4582-a0e8-109219560401
Cadman, B.
49a6a7ae-f3a0-49da-9f22-2840319f4d62
Barton, G.
82f7be35-5f09-4141-93ad-4237116f59c5
Forrest, R.
b7b11839-91f7-4543-907d-d0c1c138111a
Boxall, E.
6dda958a-a662-4354-98a8-a7de5b8c284b
Timmins, A.
fd8a0347-c071-40a9-89ba-5acc3dae3035
Borthwick, M.
cf7d2af4-9ac8-470a-ac61-d5e6e673194b
Thacker, M.
bac5941d-27ba-4d35-ace7-36dcf57073b4

Shulman, R., McKenzie, C.A. and Landa, J. , PROTECTED-UK GROUP (2015) Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK). Journal of Critical Care, 30 (4), 808-813. (doi:10.1016/j.jcrc.2015.04.008).

Record type: Article

Abstract

Purpose
The purpose was to describe clinical pharmacist interventions across a range of critical care units (CCUs) throughout the United Kingdom, to identify CCU medication error rate and prescription optimization, and to identify the type and impact of each intervention in the prevention of harm and improvement of patient therapy.

Materials and methods
A prospective observational study was undertaken in 21 UK CCUs from November 5 to 18, 2012. A data collection web portal was designed where the specialist critical care pharmacist reported all interventions at their site. Each intervention was classified as medication error, optimization, or consult. In addition, a clinical impact scale was used to code the interventions. Interventions were scored as low impact, moderate impact, high impact, and life saving. The final coding was moderated by blinded independent multidisciplinary trialists.

Results
A total of 20 517 prescriptions were reviewed with 3294 interventions recorded during the weekdays. This resulted in an overall intervention rate of 16.1%: 6.8% were classified as medication errors, 8.3% optimizations, and 1.0% consults. The interventions were classified as low impact (34.0%), moderate impact (46.7%), and high impact (19.3%); and 1 case was life saving. Almost three quarters of interventions were to optimize the effectiveness of and improve safety of pharmacotherapy.

Conclusions
This observational study demonstrated that both medication error resolution and pharmacist-led optimization rates were substantial. Almost 1 in 6 prescriptions required an intervention from the clinical pharmacist. The error rate was slightly lower than an earlier UK prescribing error study (EQUIP). Two thirds of the interventions were of moderate to high impact.

This record has no associated files available for download.

More information

e-pub ahead of print date: 9 June 2015
Published date: August 2015

Identifiers

Local EPrints ID: 479361
URI: http://eprints.soton.ac.uk/id/eprint/479361
ISSN: 0883-9441
PURE UUID: 00b72513-4c30-4482-857c-b076564dac3f
ORCID for C.A. McKenzie: ORCID iD orcid.org/0000-0002-5190-9711

Catalogue record

Date deposited: 20 Jul 2023 17:34
Last modified: 17 Mar 2024 04:23

Export record

Altmetrics

Contributors

Author: R. Shulman
Author: C.A. McKenzie ORCID iD
Author: J. Landa
Author: R.S. Bourne
Author: A. Jones
Author: M. Borthwick
Author: M. Tomlin
Author: Y.H. Jani
Author: D. West
Author: I. Bates
Author: Rob Shulman
Author: C. Mc
Author: J. Landa
Author: R. Bourne
Author: M. Tomlin
Author: B. Ian
Author: D. West
Author: Y. Jani
Author: D. Sapsford
Author: H. McHale
Author: J. Hylands
Author: E. Graham-Clarke
Author: N. Rudall
Author: B. Cadman
Author: G. Barton
Author: R. Forrest
Author: E. Boxall
Author: A. Timmins
Author: M. Borthwick
Author: M. Thacker
Corporate Author: PROTECTED-UK GROUP

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×